Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crown Pacific Biotechnology is a Singapore-based biotechnology company specializing in the development and manufacture of high-quality premixes and feed additives for the livestock and aquaculture industries. As a wholly-owned subsidiary of the Charoen Pokphand Group, the company leverages advanced technology and stringent quality standards (GMP, HACCP, FAMI-QS) to produce a wide range of nutritional supplements, including vitamins, minerals, and enzymes. Its product portfolio, featuring brands like VitaLink and PhyLink, is designed to optimize animal growth, immunity, and overall performance across Asian markets. The company operates a state-of-the-art, fully automated manufacturing facility in Singapore's Jurong Industrial Estate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crown Pacific.